Multidisciplinary treatment of hepatocellular carcinoma in 2023 Italian practice Treatment Guidelines of the Italian Association for the Study of the Liver (AISF), Italian Association of Medical Oncology (AIOM), Italian Association of Hepato-Bilio-Pancreatic Surgery (AICEP) Italian Association of Hospital Gastroenterologists (AIGO), Italian Association of Radiology and Clinical Oncology (AIRO), Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP), Italian Society of Surgery (SIC), Italian Society of Gastroenterology (SIGE) Italian Society of Medical and Interventional Radiology (SIRM), Italian Organ Transplant Society (SITO), and Association of Patients with Hepatitis and Liver Disease (EpaC) - Part II - Non-surgical treatments

被引：12

作者：

Cabibbo, Giuseppe ^{[1
,29
]}

Daniele, Bruno ^{[1
]}

Borzio, Mauro ^{[2
]}

Casadei-Gardini, Andrea ^{[3
]}

Cillo, Umberto ^{[4
]}

Colli, Agostino ^{[5
]}

Conforti, Massimiliano ^{[6
]}

Dadduzio, Vincenzo ^{[7
]}

Dionisi, Francesco ^{[8
]}

Farinati, Fabio ^{[9
]}

Gardini, Ivan ^{[6
]}

Giannini, Edoardo Giovanni ^{[10
]}

Golfieri, Rita ^{[11
,12
]}

Guido, Maria ^{[13
]}

Mega, Andrea ^{[14
]}

Cinquini, Michela ^{[15
,16
]}

Piscaglia, Fabio ^{[17
,18
]}

Rimassa, Lorenza ^{[19
,20
]}

Romanini, Laura ^{[21
]}

Pecorelli, Anna ^{[22
]}

Sacco, Rodolfo ^{[23
]}

Scorsetti, Marta ^{[24
,25
]}

Vigano, Luca ^{[26
,27
]}

Vitale, Alessandro ^{[5
]}

Trevisani, Franco ^{[18
,28
,30
]}

机构：

[1] Univ Palermo, Dept Hlth Promot Mother & Child Care, Sect Gastroenterol & Hepatol, Gastroenterol Unit,Azienda Osped Univ Policlin Pao, Palermo, Italy

[2] ASL Napoli Ctr 1, Osped Mare, Oncol Unit, Naples, Italy

[3] Ctr Diagnost Italiano CDI, Milan, Italy

[4] Univ Vita Salute San Raffaele, IRCCS San Raffaele Sci Inst Hosp, Dept Oncol, Milan, Italy

[5] Padua Univ Hosp, Gen Surg Hepatopancreato Biliary Surg & Liver Tran, I-35128 Padua, Italy

[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dipartimento Med Trasfus & Ematol, Milan, Italy

[7] Italian Liver Patient Assoc, EpaC Onlus, Turin, Italy

[8] Mons AR Dimiccoli Hosp, Med Oncol Unit, ASL BT, Barletta, Italy

[9] IRCCS Regina Elena Natl Canc Inst, Dept Radiat Oncol, Rome, Italy

[10] Univ Padua, Dept Surg Oncol & Gastroenterol, I-35128 Padua, Italy

[11] Univ Genoa, IRCCS Osped Policlin San Martino, Dept Internal Med, Gastroenterol Unit, Genoa, Italy

[12] Bologna Univ, Alma Mater Studiorum, Bologna, Italy

[13] Madre Fortunata Toniolo Private Hosp, Radiol Ctr Medipass Bologna, Radiol Unit, Bologna, Italy

[14] Univ Padua, Dept Med, Padua, Italy

[15] Reg Hosp Bolzano, Dept Gastronterol, Bolzano, Italy

[16] IRCCS, Ist Ric Farmacol Mario Negri, Oncol Dept, Milan, Italy

[17] IRCCS Azienda Osped Univ Bologna, Div Internal Med Hepatobiliary & Immunoallerg Dis, Bologna, Italy

[18] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy

[19] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20072 Pieve Emanuele, Milan, Italy

[20] IRCCS Humanitas Res Hosp, Med Oncol & Hematol Unit, Via Manzoni 56, I-20089 Milan, Italy

[21] ASST Cremona, Osped Cremona, Radiol Unit, Cremona, Italy

[22] IRCCS Azienda Osped Univ Bologna, Dept Radiol, Bologna, Italy

[23] Univ Foggia, Dept Surg & Med Sci, Gastroenterol & Endoscopy Unit, I-71100 Foggia, Italy

[24] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, Milan, Italy

[25] Humanitas Res Hosp IRCCS, Dept Radiotherapy & Radiosurg, Via Manzoni 56, I-20089 Rozzano, Milan, Italy

[26] Humanitas Gavazzeni Univ Hosp, Dept Minimally Invas Gen & Oncol Surg, Hepatobiliary Unit, Viale M Gavazzeni 21, I-24125 Bergamo, Italy

[27] IRCCS Azienda Osped Univ Bologna, Unit Semeiot, Liver & Alcohol Related Dis, I-40138 Bologna, Italy

[28] Humanitas Univ, Dept Biomed Sci, Viale Rita Levi Montalcini 4, I-20090 Milan, Italy

[29] Univ Palermo, Dept Hlth Promot Mother & Child Care, Sect Gastroenterol & Hepatol, Internal Med & Med Specialties PROMISE, Piazza Clin 2, I-90127 Palermo, Italy

[30] IRCCS Azienda Osped Univ Bologna, Unit Semeiot Liver & Alcohol related Dis, I-40138 Bologna, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2024年 / 56卷 / 03期

关键词：

GRADE; Guideline; Hepatocellular carcinoma; Immunotherapy; Liver cancer; Multidisciplinary board; Survival; Systemic therapy; ATEZOLIZUMAB PLUS BEVACIZUMAB; BEAD TRANSARTERIAL CHEMOEMBOLIZATION; STEREOTACTIC BODY RADIOTHERAPY; DOXORUBICIN-ELUTING BEADS; COST-EFFECTIVENESS; RADIOFREQUENCY ABLATION; CONVENTIONAL CHEMOEMBOLIZATION; OPEN-LABEL; ARTERIAL CHEMOEMBOLIZATION; Y-90; RADIOEMBOLIZATION;

D O I：

10.1016/j.dld.2023.10.028

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Worldwide, hepatocellular carcinoma (HCC) is the third most common cause of cancer -related death. The remarkable improvements in treating HCC achieved in the last years have increased the complexity of its management. Following the need to have updated guidelines on the multidisciplinary treatment management of HCC, the Italian Scientific Societies involved in the management of this cancer have promoted the drafting of a new dedicated document. This document was drawn up according to the GRADE methodology needed to produce guidelines based on evidence. Here is presented the second part of guidelines, focused on the multidisciplinary tumor board of experts and non -surgical treatments of HCC. (c) 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

引用

页码：394 / 405

页数：12

共 112 条

[1] Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Abou-Alfa, G. K.
Meyer, T.
Cheng, A. -L.
El-Khoueiry, A. B.
Rimassa, L.
Ryoo, B. -Y.
Cicin, I.
Merle, P.
Chen, Y. H.
Park, J. -W.
Blanc, J. -F.
Bolondi, L.
Klumpen, H. -J.
Chan, S. L.
Zagonel, V.
Pressiani, T.
Ryu, M. -H.
Venook, A. P.
Hessel, C.
Borgman-Hagey, A. E.
Schwab, G.
Kelley, R. K.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) : 54 - 63
[2] Abou-Alfa Ghassan K, 2022, NEJM Evid, V1, pEVIDoa2100070, DOI 10.1056/EVIDoa2100070
[3] Association of adverse events (AEs) with efficacy outcomes for cabozantinib (C) in patients (pts) with advanced hepatocellular carcinoma (aHCC) in the phase III CELESTIAL trial.
Abou-Alfa, Ghassan K.
Meyer, Tim
Cheng, Ann-Lii
Cicin, Irfan
Bolondi, Luigi
Klumpen, Heinz Josef
Chan, Stephen Lam
Dadduzio, Vincenzo
Milwee, Steven
Dubey, Sarita
Kelley, Robin Kate
El-Khoueiry, Anthony B.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[4] Abou-Alfa GK, 2016, Proc Am Soc Clin Oncol, V34, P4017
[5] Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review
Alonso, J. C.
Casans, I
Gonzalez, F. M.
Fuster, D.
Rodriguez, A.
Sanchez, N.
Oyaguez, I
Burgos, R.
Williams, A. O.
Espinoza, N.
[J]. BMC GASTROENTEROLOGY, 2022, 22 (01)
[6] [Anonymous], 2020, CNEC - Centro Nazionale per l'Eccellenza delle Cure Manuale metodologico per la Produzione di Linee Guida di Pratica Clinica
[7] [Anonymous], 2021, GRADEpro gdt [Computer program] mcmaster university (developed by evidence prime) GRADEpro gdt
[8] Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child-Pugh B cirrhosis
Blanc, Jean-Frederic
Khemissa, Faiza
Bronowicki, Jean-Pierre
Monterymard, Carole
Perarnau, Jean-Marc
Bourgeois, Vincent
Obled, Stephane
Abdelghani, Meher Ben
Mabile-Archambeaud, Isabelle
Faroux, Roger
Seitz, Jean-Francois
Locher, Christophe
Senellart, Helene
Villing, Anne-Laure
Audemar, Franck
Costentin, Charlotte
Deplanque, Gael
Manfredi, Sylvain
Edeline, Julien
[J]. HEPATOLOGY INTERNATIONAL, 2021, 15 (01) : 93 - 104
[9] TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
Brown, Andrew M.
Kassab, Ihab
Massani, Marco
Townsend, Whitney
Singal, Amit G.
Soydal, Cigdem
Moreno-Luna, Laura
Roberts, Lewis R.
Chen, Vincent L.
Parikh, Neehar D.
[J]. CANCER MEDICINE, 2023, 12 (03): : 2590 - 2599
[10] Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Bruix, Jordi
Qin, Shukui
Merle, Philippe
Granito, Alessandro
Huang, Yi-Hsiang
Bodoky, Gyrogy
Pracht, Marc
Yokosuka, Osamu
Rosmorduc, Olivier
Breder, Valeriy
Gerolami, Rene
Masi, Gianluca
Ross, Paul J.
Song, Tianqiang
Bronowicki, Jean-Pierre
Ollivier-Hourmand, Isabelle
Kudo, Masatoshi
Cheng, Ann-Lii
Llovet, Josep M.
Finn, Richard S.
LeBerre, Marie-Aude
Baumhauer, Annette
Meinhardt, Gerold
Han, Guohong
[J]. LANCET, 2017, 389 (10064) : 56 - 66

← 1 2 3 4 5 6 7 8 9 10 →